New insider Mcgowan Lindsey claimed ownership of 4,478 units of Ordinary Shares (SEC Form 3)
$STE
Industrial Specialties
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/01/2026 |
3. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares | 4,230(1) | D | |
| Ordinary Shares | 248 | I | See Footnote Below(2) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (3) | 05/31/2033 | Ordinary Shares | 2,480 | $219.97 | D | |
| Employee Stock Option (right to buy) | (4) | 06/04/2034 | Ordinary Shares | 2,008 | $251.34 | D | |
| Employee Stock Option (right to buy) | (5) | 06/03/2035 | Ordinary Shares | 2,056 | $267.66 | D | |
| Explanation of Responses: |
| 1. As of January 1, 2026, 2,952 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 660 on May 31, 2026; 1,128 on June 2, 2026; 588 on June 4, 2027 and 576 on June 3, 2028. |
| 2. Units representing 248 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of January 2, 2026. |
| 3. 1,240 of these options are exercisable. This option becomes exercisable as follows: 620 on June 1, 2026 and 620 on May 31, 2027. |
| 4. 502 of these options are exercisable. This option becomes exercisable as follows: 502 on June 4, 2026; 502 on June 4, 2027 and 502 on June 5, 2028. |
| 5. This option becomes exercisable as follows: 514 on June 3, 2026; 514 on June 3, 2027; 514 on June 5, 2028 and 514 on June 4, 2029. |
| Remarks: |
| Exhibit 24 - Power of Attorney |
| /s/ John P. Ubbing, Authorized Representative under Power of Attorney | 01/06/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||